Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0087 | 0.4153 | 0.5 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Schistosoma mansoni | lipoxygenase | 0.0122 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0122 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.4153 | 1 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Schistosoma mansoni | lipoxygenase | 0.0086 | 0.3984 | 0.3984 |
Leishmania major | sodium/sulphate symporter, putative | 0.0087 | 0.4153 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0087 | 0.4153 | 0.5 |
Brugia malayi | NaDC-2 | 0.0087 | 0.4153 | 1 |
Echinococcus multilocularis | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Trichomonas vaginalis | sodium-dependent high-affinity dicarboxylate transporter, putative | 0.0087 | 0.4153 | 0.5 |
Echinococcus granulosus | solute carrier family 13 | 0.0087 | 0.4153 | 0.4153 |
Trichomonas vaginalis | Inorganic phosphate transporter, putative | 0.0087 | 0.4153 | 0.5 |
Schistosoma mansoni | sodium/dicarboxylate cotransporter-related | 0.0087 | 0.4153 | 0.4153 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.